Literature DB >> 6427297

Immunoglobulin and other proteins in the cerebrospinal fluid of patients with Alzheimer's disease.

H M Chapel, M M Esiri, G K Wilcock.   

Abstract

Immunoglobulin has been measured and studied electrophoretically in cerebrospinal fluid (CSF) from 14 patients with Alzheimer's disease and 25 undemented controls. Presence or absence of the diagnosis of Alzheimer's disease was confirmed histologically, as these were postmortem specimens. There was no increased incidence of oligoclonal IgG bands in either group, and no significant differences in the levels of IgG and albumin. Non-immunoglobulin bands were found in the gamma region in some samples from Alzheimer's disease patients and controls; such bands are not found in the CSF from younger patients. There was a significantly increased incidence of double transferrin and double tau protein bands in the Alzheimer's group, suggesting that further studies of genetic markers might be worthwhile.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6427297      PMCID: PMC498849          DOI: 10.1136/jcp.37.6.697

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Demonstration of CSF gamma-globulin banding in presenile dementia.

Authors:  A Williams; N Papadopoulos; T N Chase
Journal:  Neurology       Date:  1980-08       Impact factor: 9.910

2.  Complement C4 allotypes in Alzheimer's disease.

Authors:  C W Nerl; R Mayeux; G J O'Neill
Journal:  Lancet       Date:  1982-12-11       Impact factor: 79.321

3.  Oligoclonal immunoglobulins and plasma cells in spinal fluid of patients with multiple sclerosis.

Authors:  E J Thompson; P Kaufmann; R C Shortman; P Rudge; W I McDonald
Journal:  Br Med J       Date:  1979-01-06

4.  Antibody synthesis within the central nervous system: comparisons of CSF IgG indices and electrophoresis.

Authors:  E J Thompson; P G Riches; J Kohn
Journal:  J Clin Pathol       Date:  1983-03       Impact factor: 3.411

5.  Alzheimer's disease and HLA.

Authors:  P J Henschke; D A Bell; R D Cape
Journal:  Tissue Antigens       Date:  1978-08

6.  Plaques, tangles and dementia. A quantitative study.

Authors:  G K Wilcock; M M Esiri
Journal:  J Neurol Sci       Date:  1982-11       Impact factor: 3.181

7.  Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.

Authors:  G K Wilcock; M M Esiri; D M Bowen; C C Smith
Journal:  J Neurol Sci       Date:  1982-12       Impact factor: 3.181

8.  Oligoclonal immunoglobulins in cerebrospinal fluid in acute cerebrovascular disease.

Authors:  B Roström; B Link
Journal:  Neurology       Date:  1981-05       Impact factor: 9.910

9.  Oligoclonal IgG bands in cerebrospinal fluid in various neurological diseases.

Authors:  A B Chu; J L Sever; D L Madden; M Iivanainen; M Leon; W Wallen; B R Brooks; Y J Lee; S Houff
Journal:  Ann Neurol       Date:  1983-04       Impact factor: 10.422

10.  HLA antigens in Alzheimer's disease.

Authors:  R Sulkava; S Koskimies; J Wikström; J Palo
Journal:  Tissue Antigens       Date:  1980-08
  10 in total
  4 in total

Review 1.  Systemic and brain metabolic dysfunction as a new paradigm for approaching Alzheimer's dementia.

Authors:  Vincenzo Giordano; Gianfranco Peluso; Maurizio Iannuccelli; Paola Benatti; Raffaella Nicolai; Menotti Calvani
Journal:  Neurochem Res       Date:  2006-08-17       Impact factor: 3.996

2.  Cerebral amyloid angiopathy in dementia and old age.

Authors:  M M Esiri; G K Wilcock
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-11       Impact factor: 10.154

3.  Integrity of the blood-CSF barrier in dementia of Alzheimer type: CSF/serum ratios of albumin and IgG.

Authors:  L Frölich; J Kornhuber; R Ihl; J Fritze; K Maurer; P Riederer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

Review 4.  From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy.

Authors:  Morvane Colin; Simon Dujardin; Susanna Schraen-Maschke; Guy Meno-Tetang; Charles Duyckaerts; Jean-Philippe Courade; Luc Buée
Journal:  Acta Neuropathol       Date:  2019-11-04       Impact factor: 17.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.